Recruitment

Recruitment Status
Completed
Estimated Enrollment
800

Inclusion Criterias

Newly diagnosed with non-metastatic prostate cancer
Provide informed consent
Has not yet started radiation or surgery
Newly diagnosed with non-metastatic prostate cancer
Provide informed consent
Has not yet started radiation or surgery

Exclusion Criterias

Unable to communicate in English
Has already begun treatment for prostate cancer
Distant, metastatic prostate cancer at diagnosis
Unable to communicate in English
Has already begun treatment for prostate cancer
Distant, metastatic prostate cancer at diagnosis

Summary

Conditions
Prostate Cancer
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: Single (Investigator)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Only males

Description

The objective is to test the comparative effectiveness of a conjoint analysis decision aid intervention compared to usual care. The investigators will identify preferred attributes of prostate cancer treatments that will help in designing a conjoint analysis decision aid to help patients weigh treat...

The objective is to test the comparative effectiveness of a conjoint analysis decision aid intervention compared to usual care. The investigators will identify preferred attributes of prostate cancer treatments that will help in designing a conjoint analysis decision aid to help patients weigh treatment attributes. The investigators will employ values markers to represent clusters of values for particular aspects of treatments that are valued most by individual patients. The investigators will test if the concordance between values markers and treatment received is predictive of objective outcomes and subjective outcomes. The study hypothesis is that conjoint task may help in treatment choice and prostate cancer patients whose treatment is more concordant with their values markers will have improved outcomes.

Inclusion Criterias

Newly diagnosed with non-metastatic prostate cancer
Provide informed consent
Has not yet started radiation or surgery
Newly diagnosed with non-metastatic prostate cancer
Provide informed consent
Has not yet started radiation or surgery

Exclusion Criterias

Unable to communicate in English
Has already begun treatment for prostate cancer
Distant, metastatic prostate cancer at diagnosis
Unable to communicate in English
Has already begun treatment for prostate cancer
Distant, metastatic prostate cancer at diagnosis

Locations

Philadelphia, Pennsylvania, 19111
Philadelphia, Pennsylvania, 19104
Philadelphia, Pennsylvania, 19104
Philadelphia, Pennsylvania, 19111
Philadelphia, Pennsylvania, 19104
Philadelphia, Pennsylvania, 19104

Tracking Information

NCT #
NCT02032550
Collaborators
  • Patient-Centered Outcomes Research Institute
  • Corporal Michael J. Crescenz VA Medical Center
  • Fox Chase Cancer Center
Investigators
  • Principal Investigator: Ravishankar Jayadevappa, PhD University of Pennsylvania
  • Ravishankar Jayadevappa, PhD University of Pennsylvania